Corcept Therapeutics Inc (CORT)
22.99
+0.68
(+3.05%)
USD |
NASDAQ |
Apr 23, 16:00
22.99
0.00 (0.00%)
After-Hours: 19:15
Corcept Therapeutics Free Cash Flow (Quarterly): 5.887M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.887M |
| September 30, 2023 | 52.87M |
| June 30, 2023 | 42.18M |
| March 31, 2023 | 25.96M |
| December 31, 2022 | 33.36M |
| September 30, 2022 | 33.30M |
| June 30, 2022 | 18.02M |
| March 31, 2022 | 35.24M |
| December 31, 2021 | 49.36M |
| September 30, 2021 | 48.54M |
| June 30, 2021 | 44.22M |
| March 31, 2021 | 25.30M |
| December 31, 2020 | 34.64M |
| September 30, 2020 | 29.73M |
| June 30, 2020 | 53.14M |
| March 31, 2020 | 33.23M |
| December 31, 2019 | 48.32M |
| September 30, 2019 | 38.14M |
| June 30, 2019 | 25.14M |
| March 31, 2019 | 23.42M |
| December 31, 2018 | 21.41M |
| September 30, 2018 | 44.46M |
| June 30, 2018 | 15.15M |
| March 31, 2018 | 34.35M |
| December 31, 2017 | 24.85M |
| Date | Value |
|---|---|
| September 30, 2017 | 10.84M |
| June 30, 2017 | 15.37M |
| March 31, 2017 | 9.451M |
| December 31, 2016 | 4.494M |
| September 30, 2016 | 8.845M |
| June 30, 2016 | 1.583M |
| March 31, 2016 | 3.275M |
| December 31, 2015 | 4.18M |
| September 30, 2015 | 0.883M |
| June 30, 2015 | -0.139M |
| March 31, 2015 | -1.811M |
| December 31, 2014 | -1.403M |
| September 30, 2014 | -5.945M |
| June 30, 2014 | -9.032M |
| March 31, 2014 | -11.17M |
| December 31, 2013 | -7.706M |
| September 30, 2013 | -8.667M |
| June 30, 2013 | -9.24M |
| March 31, 2013 | -11.57M |
| December 31, 2012 | -8.80M |
| September 30, 2012 | -9.281M |
| June 30, 2012 | -7.926M |
| March 31, 2012 | -10.16M |
| December 31, 2011 | -6.294M |
| September 30, 2011 | -6.604M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
5.887M
Minimum
Dec 2023
53.14M
Maximum
Jun 2020
35.61M
Average
34.64M
Median
Dec 2020
Free Cash Flow (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical Inc | -85.50M |
| Alnylam Pharmaceuticals Inc | -45.10M |
| Catalyst Pharmaceuticals Inc | 53.33M |
| United Therapeutics Corp | 72.00M |
| XOMA Corp | -3.927M |